These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12824745)

  • 1. Effects of haloperidol and atypical neuroleptics on psychomotor performance and driving ability in schizophrenic patients. Results from an experimental study.
    Kagerer S; Winter C; Möller HJ; Soyka M
    Neuropsychobiology; 2003; 47(4):212-8. PubMed ID: 12824745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of haloperidol and risperidone on psychomotor performance relevant to driving ability in schizophrenic patients compared to healthy controls.
    Soyka M; Winter C; Kagerer S; Brunnauer M; Laux G; Möller HJ
    J Psychiatr Res; 2005 Jan; 39(1):101-8. PubMed ID: 15504428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cognition and driving in schizophrenic patients under treatment with risperidone vs. haloperidol].
    Dittert S; Soyka M; Winter C; Möller HJ
    Fortschr Neurol Psychiatr; 1999 Nov; Suppl 2():S70-3. PubMed ID: 10598340
    [No Abstract]   [Full Text] [Related]  

  • 4. The impact of antipsychotics on psychomotor performance with regards to car driving skills.
    Brunnauer A; Laux G; Geiger E; Möller HJ
    J Clin Psychopharmacol; 2004 Apr; 24(2):155-60. PubMed ID: 15206662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of clozapine and typical neuroleptics on information processing of the central nervous system under clinical conditions in schizophrenic disorders: implications for fitness to drive.
    Grabe HJ; Wolf T; Grätz S; Laux G
    Neuropsychobiology; 1999 Nov; 40(4):196-201. PubMed ID: 10559702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of sensorimotor and cognitive performance of acute schizophrenic inpatients treated with remoxipride or haloperidol.
    Classen W; Laux G
    Neuropsychobiology; 1989; 21(3):131-40. PubMed ID: 2575719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of D2- and D4-blocking neuroleptics on the procedural learning of schizophrenic patients.
    Bédard MA; Scherer H; Delorimier J; Stip E; Lalonde P
    Can J Psychiatry; 1996 Sep; 41(7 Suppl 1):S21-4. PubMed ID: 8884048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Driving simulator performance and psychomotor functions of schizophrenic patients treated with antipsychotics.
    Brunnauer A; Laux G; Zwick S
    Eur Arch Psychiatry Clin Neurosci; 2009 Dec; 259(8):483-9. PubMed ID: 19593580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of haloperidol on the relationship of frontal lobe function to psychomotor poverty and disorganization syndromes.
    Allen DN; Anastasiou A; Goldstein G; Gilbertson M; van Kammen DP
    Psychiatry Res; 2000 Feb; 93(1):33-9. PubMed ID: 10699226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensorimotor and cognitive performance of schizophrenic inpatients treated with haloperidol, flupenthixol, or clozapine.
    Classen W; Laux G
    Pharmacopsychiatry; 1988 Nov; 21(6):295-7. PubMed ID: 2907629
    [No Abstract]   [Full Text] [Related]  

  • 12. Do neuroleptics impair learning in schizophrenic patients?
    Cutmore TR; Beninger RJ
    Schizophr Res; 1990; 3(3):173-86. PubMed ID: 1980612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine.
    Schlagenhauf F; Juckel G; Koslowski M; Kahnt T; Knutson B; Dembler T; Kienast T; Gallinat J; Wrase J; Heinz A
    Psychopharmacology (Berl); 2008 Mar; 196(4):673-84. PubMed ID: 18097655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of depot neuroleptics on driving performance in chronic schizophrenic patients.
    Wylie KR; Thompson DJ; Wildgust HJ
    J Neurol Neurosurg Psychiatry; 1993 Aug; 56(8):910-3. PubMed ID: 8102393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidol.
    Gallhofer B; Jaanson P; Mittoux A; Tanghøj P; Lis S; Krieger S
    Pharmacopsychiatry; 2007 Nov; 40(6):275-86. PubMed ID: 18030652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antipsychotics on cognitive performance in drug-naive schizophrenic patients.
    Lee SM; Chou YH; Li MH; Wan FJ; Yen MH
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1101-7. PubMed ID: 17475386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between negative symptoms of schizophrenia and extrapyramidal side effects with haloperidol and olanzapine.
    Allan ER; Sison CE; Alpert M; Connolly B; Crichton J
    Psychopharmacol Bull; 1998; 34(1):71-4. PubMed ID: 9564201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Driving ability under sertindole.
    Brunnauer A; Laux G
    Pharmacopsychiatry; 2012 Mar; 45(2):47-50. PubMed ID: 21989603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial.
    Shim JC; Shin JG; Kelly DL; Jung DU; Seo YS; Liu KH; Shon JH; Conley RR
    Am J Psychiatry; 2007 Sep; 164(9):1404-10. PubMed ID: 17728426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia.
    Rémillard S; Pourcher E; Cohen H
    J Int Neuropsychol Soc; 2008 Jan; 14(1):110-8. PubMed ID: 18078537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.